ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 146 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q2 2023. The put-call ratio across all filers is 1.73 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $300 | -49.1% | 9,499 | -58.8% | 0.00% | -66.7% |
| Q3 2023 | $589 | -3.0% | 23,037 | +8.8% | 0.01% | +20.0% |
| Q2 2023 | $607 | -16.0% | 21,176 | -29.8% | 0.01% | -16.7% |
| Q1 2023 | $723 | +42.9% | 30,164 | +1.2% | 0.01% | -14.3% |
| Q4 2022 | $506 | -99.9% | 29,816 | -37.3% | 0.01% | -22.2% |
| Q3 2022 | $705,000 | -32.7% | 47,552 | +116.8% | 0.01% | -35.7% |
| Q3 2021 | $1,048,000 | +3.7% | 21,937 | -5.9% | 0.01% | +40.0% |
| Q4 2020 | $1,011,000 | -36.4% | 23,302 | -37.1% | 0.01% | -68.8% |
| Q3 2020 | $1,590,000 | +1214.0% | 37,055 | +232.8% | 0.03% | +1500.0% |
| Q4 2019 | $121,000 | – | 11,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Portolan Capital Management | 484,907 | $11,807,485 | 0.97% |
| Nikko Asset Management Americas, Inc. | 1,563,065 | $37,966,849 | 0.44% |
| Diametric Capital, LP | 32,765 | $797,827 | 0.43% |
| ARK Investment Management | 1,964,964 | $47,846,871 | 0.42% |
| SummerHaven Investment Management, LLC | 23,400 | $569,790 | 0.38% |
| Quantedge Capital Pte Ltd | 40,800 | $993,480 | 0.36% |
| Granahan Investment Management | 344,549 | $8,389,768 | 0.34% |
| FEDERATED HERMES, INC. | 4,694,060 | $114,300,361 | 0.27% |
| Belmont Capital, LLC | 40,000 | $974,000 | 0.18% |
| Woodline Partners LP | 754,023 | $18,360,460 | 0.18% |